PT Pakuwon Jati Tbk (IDX:PWON)

Sage Therapeutics Balance Sheet

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7,271,968	9,154,064	7,599,820	7,444,245	6,443,643	2,886,903
Short-Term Investments	160,391	120,883	379,352	-	-	-
Cash & Short-Term Investments	7,432,359	9,274,947	7,979,172	7,444,245	6,443,643	2,886,903
Cash Growth	-17.54%	16.24%	7.19%	15.53%	123.20%	-34.08%
Accounts Receivable	83,985	140,761	110,434	101,575	105,828	101,924
Other Receivables	119,725	117,501	151,655	127,038	145,848	136,406
Receivables	203,710	258,263	262,089	228,613	251,676	238,329
Inventory	4,225,181	4,494,490	3,943,380	3,779,452	3,980,700	4,511,999
Prepaid Expenses	288,984	295,416	252,922	200,371	207,596	322,329
Other Current Assets	572,874	496,285	617,863	600,786	569,425	630,463
Total Current Assets	12,723,108	14,819,401	13,055,426	12,253,466	11,453,040	8,590,024
Property, Plant & Equipment	2,906,051	2,788,274	2,590,083	2,344,787	2,318,296	2,355,149
Long-Term Investments	4,041,386	1,994,610	1,459,338	936,110	157,860	133,696
Long-Term Deferred Tax Assets	46,602	48,832	51,224	53,159	53,548	58,229
Other Long-Term Assets	15,845,151	15,719,968	15,554,716	15,014,658	14,883,337	15,321,707
Total Assets	35,562,298	35,371,085	32,710,787	30,602,180	28,866,081	26,458,805
Accounts Payable	198,940	270,235	200,805	212,831	215,294	347,560
Accrued Expenses	299,410	301,401	256,841	236,843	208,813	201,193
Current Portion of Long-Term Debt	-	-	-	-	49,962	397,479
Current Portion of Leases	6,452	6,352	12,940	4,183	-	-
Current Income Taxes Payable	-	34,499	36,598	34,152	31,258	38,076
Current Unearned Revenue	2,423,424	2,307,247	1,846,151	1,992,815	2,372,690	3,179,813
Other Current Liabilities	840,495	187,788	178,806	152,675	140,964	172,577
Total Current Liabilities	3,768,722	3,107,522	2,532,141	2,633,500	3,018,981	4,336,698
Long-Term Debt	5,387,885	6,435,907	6,132,757	6,248,500	5,656,871	3,546,539
Long-Term Leases	-	6,596	15,452	24,209	-	-
Long-Term Unearned Revenue	145,665	329,133	546,174	349,022	430,384	360,150
Other Long-Term Liabilities	487,061	471,729	442,966	422,064	395,787	389,413
Total Liabilities	10,079,637	10,629,088	9,915,453	9,883,904	9,687,643	8,860,110
Common Stock	1,203,990	1,203,990	1,203,990	1,203,990	1,203,990	1,203,990
Additional Paid-In Capital	362,194	362,194	362,194	362,194	362,194	362,194
Retained Earnings	19,721,421	19,211,475	17,570,180	15,778,007	14,431,810	13,049,262
Comprehensive Income & Other	-84,309	-74,419	-39,785	-36,564	48,711	20,032
Total Common Equity	21,203,296	20,703,240	19,096,579	17,307,627	16,046,706	14,635,479
Minority Interest	4,279,365	4,038,757	3,698,755	3,410,649	3,131,733	2,963,216
Shareholders' Equity	25,482,661	24,741,997	22,795,334	20,718,276	19,178,438	17,598,695
Total Liabilities & Equity	35,562,298	35,371,085	32,710,787	30,602,180	28,866,081	26,458,805
Total Debt	5,394,337	6,448,856	6,161,149	6,276,892	5,706,833	3,944,018
Net Cash (Debt)	2,038,022	2,826,092	1,818,023	1,167,353	736,810	-1,057,115
Net Cash Growth	-17.12%	55.45%	55.74%	58.43%	-	-
Net Cash Per Share	42.32	58.68	37.75	24.24	15.30	-21.95
Filing Date Shares Outstanding	48,160	48,160	48,160	48,160	48,160	48,160
Total Common Shares Outstanding	48,160	48,160	48,160	48,160	48,160	48,160
Working Capital	8,954,387	11,711,879	10,523,286	9,619,966	8,434,059	4,253,326
Book Value Per Share	440.27	429.89	396.53	359.38	333.20	303.90
Tangible Book Value	21,203,296	20,703,240	19,096,579	17,307,627	16,046,706	14,635,479
Tangible Book Value Per Share	440.27	429.89	396.53	359.38	333.20	303.90
Land	313,585	313,585	288,294	288,292	288,291	288,273
Buildings	2,689,996	2,680,734	2,657,076	2,453,619	2,392,903	2,055,604
Machinery	835,916	803,362	744,149	658,533	624,012	530,786
Construction In Progress	630,096	462,192	216,762	82,347	10,391	360,192

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.